CY1120442T1 - PYRAZOLI PRODUCTS AS CALCIUM BATTERY MODIFIERS ACTIVATED BY CALCIUM RELEASE - Google Patents

PYRAZOLI PRODUCTS AS CALCIUM BATTERY MODIFIERS ACTIVATED BY CALCIUM RELEASE

Info

Publication number
CY1120442T1
CY1120442T1 CY20181100748T CY181100748T CY1120442T1 CY 1120442 T1 CY1120442 T1 CY 1120442T1 CY 20181100748 T CY20181100748 T CY 20181100748T CY 181100748 T CY181100748 T CY 181100748T CY 1120442 T1 CY1120442 T1 CY 1120442T1
Authority
CY
Cyprus
Prior art keywords
calcium
methods
activated
pyrazoli
modifiers
Prior art date
Application number
CY20181100748T
Other languages
Greek (el)
Inventor
Peyyappan Muthuppalaniappan
Srikant Viswanadha
Gayatri Swaroop Merikapudi
Swaroop Kumar V.S. Vakkalanka
Original Assignee
Rhizen Pharmaceuticals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2010/002535 external-priority patent/WO2011042797A1/en
Application filed by Rhizen Pharmaceuticals S.A. filed Critical Rhizen Pharmaceuticals S.A.
Publication of CY1120442T1 publication Critical patent/CY1120442T1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Αποκαλύπτονται νέοι αναστολείς διαύλου ασβεστίου που ενεργοποιείται δια αποδέσμευσης ασβεστίου (CRAC), μέθοδοι για την παρασκευή αυτών, φαρμακευτικές συνθέσεις που περιέχουν αυτούς και μέθοδοι για την αγωγή με τη χρήση αυτών. Η παρούσα αποκάλυψη αφορά επίσης μεθόδους για την αγωγή μη-μικροκυτταρικού καρκίνου των πνευμόνων (NSCLC) με αναστολείς CRAC και μεθόδους για την ταυτοποίηση θεραπευτικών μέσων για την αγωγή και/ή τη διάγνωση του καρκίνου.New calcium channel activated calcium channel blockers (CRACs), methods for their preparation, pharmaceutical compositions containing them, and methods for treating them are disclosed. The present disclosure also deals with methods for the treatment of non-small cell lung cancer (NSCLC) with CRAC inhibitors and methods for identifying therapeutic agents for the treatment and / or diagnosis of cancer.

CY20181100748T 2009-10-08 2018-07-17 PYRAZOLI PRODUCTS AS CALCIUM BATTERY MODIFIERS ACTIVATED BY CALCIUM RELEASE CY1120442T1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IN2439CH2009 2009-10-08
IN2636CH2009 2009-10-30
US26554009P 2009-12-01 2009-12-01
IN158CH2010 2010-01-25
IN1514CH2010 2010-06-02
IN1513CH2010 2010-06-02
PCT/IB2010/002535 WO2011042797A1 (en) 2009-10-08 2010-10-07 Pyrazole derivatives as modulators of calcium release -activated calcium channel

Publications (1)

Publication Number Publication Date
CY1120442T1 true CY1120442T1 (en) 2019-07-10

Family

ID=67180450

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100748T CY1120442T1 (en) 2009-10-08 2018-07-17 PYRAZOLI PRODUCTS AS CALCIUM BATTERY MODIFIERS ACTIVATED BY CALCIUM RELEASE

Country Status (4)

Country Link
BR (1) BR112012008209B8 (en)
CY (1) CY1120442T1 (en)
HK (1) HK1253000A1 (en)
PT (1) PT2509955T (en)

Also Published As

Publication number Publication date
BR112012008209B8 (en) 2021-09-21
BR112012008209B1 (en) 2021-07-13
HK1253000A1 (en) 2019-06-06
BR112012008209A2 (en) 2017-08-29
PT2509955T (en) 2018-08-03

Similar Documents

Publication Publication Date Title
CY1120318T1 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients
CY1122186T1 (en) CANCER TREATMENT METHODS
CY1121416T1 (en) SUBSTITUTED NUCLEOSITES, NUCLEOTIDS AND THEIR ACCOUNTS
CY1120670T1 (en) MONOCLONIC ANTIBODIES AGAINST TISSUE FACTOR INHIBITOR (TFPI)
CY1120866T1 (en) DNA-PK INHIBITORS
EA024630B9 (en) Pyrazole derivatives as calcium release-activated calcium (crac) channel inhibitors
CY1119056T1 (en) 2 ', 4', - DIFFluoro-2'-Methyl-Substituted Nucleoside Derivatization as HCV RNA Replication Inhibitors
CY1119123T1 (en) BIS-ARYLOSYCLOSED ARYLOTRIAZOLONES AND THEIR USE
EA201391114A1 (en) METHODS OF USE ALK-INHIBITORS
PH12017501500A1 (en) Methods for treating non- small cell lung cancer using tor kinase inhibitor combination therapy
CY1118216T1 (en) METHODS OF CANCER EDUCATION
EA201290139A1 (en) MODULATORS OF THE CALCIUM CHANNEL ACTIVATED BY CALCIUM RELIEF PRESENTATION OF PYRAZOL DERIVATIVES AND METHODS OF TREATMENT OF LIGHT-TERM CELL LUNG CANCER
EA201590693A1 (en) INHIBITORS GDF-8
MY177344A (en) Compounds and their methods of use
CY1124331T1 (en) INCREASED BIOAVAILABILITY OF ACTIVE SUBSTANCE IN NALTREXONE THERAPY
CY1118858T1 (en) NEW PYRIMIDINES PRODUCERS, PREPARATION OF THESE AND PHARMACEUTICAL USE OF THESE AS PHOSPHORILYLATION INSPECTORS (PKB)
CY1117000T1 (en) ENZYMAL ANTI-CANCER TREATMENT
CY1117831T1 (en) Combination Therapy For Breast Cancer Therapeutic Treatment
MX2015007053A (en) Dimeric compounds.
CY1120395T1 (en) STEROLIS PRODUCERS AND USE OF THESE FOR THE TREATMENT OF DISEASES CONCLUDING TRANSFORMED STRUCTURES OR FOR THE TREATMENT OF BLOODY BLOOD
CY1120877T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ABDOMINAL
EA201300946A1 (en) ASYMMETRIC UREA AND THEIR MEDICAL APPLICATION
CY1121973T1 (en) TREATMENT OF DRUG-RESISTANT CANCER THAT TARGETS CANCER STEM CELLS
BR112016029012A2 (en) method of treating non-small cell lung cancer and / or small cell lung cancer using thienotriazolodiazepine compounds
CY1123438T1 (en) PROCEDURE FOR THE PRODUCTION AND PURIFICATION OF RECOMBINANT LYSOSOMIC ALPHA-MANNOSIDASE